Northeast Pharmaceutical Group Co., Ltd. (SHE:000597)
China flag China · Delayed Price · Currency is CNY
5.32
-0.11 (-2.03%)
Apr 9, 2026, 2:40 PM CST

SHE:000597 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
7,7497,4497,5317,6469,0518,384
Market Cap Growth
9.99%-1.09%-1.49%-15.52%7.95%22.43%
Enterprise Value
6,4335,4454,7785,6677,4848,815
Last Close Price
5.435.225.175.135.955.85
PE Ratio
30.1728.6418.3821.3325.8484.66
Forward PE
-24.8624.8624.8624.8624.86
PS Ratio
1.101.051.000.931.031.03
PB Ratio
1.371.311.351.481.921.95
P/TBV Ratio
1.641.581.681.792.372.42
P/FCF Ratio
7.687.3912.5721.7610.4713.38
P/OCF Ratio
7.006.739.9313.038.1611.23
EV/Sales Ratio
0.910.770.640.690.851.08
EV/EBITDA Ratio
6.255.364.696.229.9212.20
EV/EBIT Ratio
12.9010.9210.0415.4834.0941.85
EV/FCF Ratio
6.385.407.9716.138.6614.07
Debt / Equity Ratio
0.380.380.290.420.470.58
Debt / EBITDA Ratio
2.092.091.532.322.813.27
Debt / FCF Ratio
2.132.132.666.212.543.97
Net Debt / Equity Ratio
-0.26-0.26-0.52-0.67-0.35-0.01
Net Debt / EBITDA Ratio
-1.43-1.43-2.82-3.80-2.18-0.09
Net Debt / FCF Ratio
-1.44-1.44-4.80-9.87-1.91-0.10
Asset Turnover
0.520.520.510.570.650.64
Inventory Turnover
3.543.543.533.974.504.04
Quick Ratio
0.950.950.870.860.780.65
Current Ratio
1.151.151.051.020.940.83
Return on Equity (ROE)
3.88%3.88%7.89%7.62%7.93%2.27%
Return on Assets (ROA)
2.28%2.28%2.00%1.57%1.02%1.04%
Return on Invested Capital (ROIC)
9.40%10.30%15.47%11.86%4.09%3.53%
Return on Capital Employed (ROCE)
7.90%7.90%7.70%6.40%4.10%4.20%
Earnings Yield
3.36%3.49%5.44%4.69%3.87%1.18%
FCF Yield
13.02%13.54%7.96%4.59%9.55%7.47%
Dividend Yield
1.82%-1.93%1.95%1.68%0.24%
Payout Ratio
75.71%75.71%50.30%61.31%31.25%167.14%
Buyback Yield / Dilution
-2.23%-2.23%1.43%-2.34%0.97%-15.42%
Total Shareholder Return
-0.41%-2.23%3.37%-0.40%2.65%-15.18%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.